Circulating miR ‐130 and its target PPAR‐γ may be potential biomarkers in patients of coronary artery disease with type 2 diabetes mellitus

ConclusionCirculating miR ‐130 may regulate the expression of PPAR‐γ and can be used as a biomarker to discriminate DM2‐CAD from CAD.

Source: Molecular Genetics & Genomic Medicine - July 31, 2019 Category: Genetics & Stem Cells Authors: Yonggang Yuan, Wanzhong Peng, Yongxing Liu, Zesheng Xu Tags: ORIGINAL ARTICLE Source Type: research